Here's why the InvoCare (ASX:IVC) share price is on the rise today

Here's why the InvoCare Limited (ASX:IVC) share price is on the move on Monday…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The InvoCare Limited (ASX: IVC) share price is on the move on Monday following the release of an announcement.

In morning trade the funeral company's shares are up 1% to $11.56.

What did InvoCare announce?

This morning InvoCare provided an update on the appointment of its new Chief Executive Officer, Olivier Chretien.

According to the release, Mr Chretien has now been formally appointed to the board of InvoCare effective 4 January 2021.

This follows the resignation of former Chief Executive Officer, Martin Earp, as a director of InvoCare this morning as planned.

Mr Earp will continue to work with the board and Mr Chretien up to the end of March 2021. The company expects this to deliver a smooth and seamless handover of leadership.

Who is the company's new CEO?

Olivier Chretien was named the company's new CEO just before Christmas following a six-month search for a replacement for the outgoing Martin Earp. The latter revealed in June that he would not be staying on when his six-year contract ends in March 2021.

Mr Chretien is an experienced executive and has previously worked for private hospital operator Ramsay Health Care Limited (ASX: RHC) and conglomerate Wesfarmers Ltd (ASX: WES). His most recent role was Group Chief Strategy Officer at Ramsay Health Care.

Prior to joining Ramsay, he served in a range of senior executive and managing director roles at Wesfarmers between 2006 and 2017.

Commenting on the appointment, InvoCare's Chair, Bart Vogel, said: "Olivier has a proven record with successful P&L management, value creation, strategy design and execution in those roles over many years. Olivier's record demonstrates strategic execution and financial acumen, combined with successful management of operational transformation and a clear grasp of trends driving business disruption across all sectors, particularly in digital and data."

"This combination of strategic and management execution to create value, together with strong people skills is critical to InvoCare's investment program and operations as we address changing customer expectations and further diversify earnings into adjacencies," he added.

Mr Chretien appears to be up for the challenge of leading the company.

He commented: "I am inspired by the Company's mission and values and the critical role it plays in celebrating life and memories for its client families, through dedicated team members who bring uniquely empathetic skills to work every day."

"I am committed to develop with the team an even more resilient and innovative business to ultimately deliver solid and sustainable returns to our shareholders by leveraging the foundations built over the past few years," he concluded.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Wesfarmers Limited. The Motley Fool Australia has recommended InvoCare Limited and Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

5 mini houses on a pile of coins.
Opinions

2 ASX shares I'd much rather buy than an investment property

Certain ASX shares can offer exposure to real estate with more income potential.

Read more »

A man holding a cup of coffee puts his thumb up and smiles with a laptop open.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

Down 43% this week, are Cochlear shares now the best bargain buy of the year?

A leading analyst believes the historic selloff in Cochlear shares could present a unique buying opportunity.

Read more »

A businessman wears armour and holds a shield and sword.
Share Market News

Nervous investors turn to ASX 200 defensives as global energy shock drags on

ASX investors sought safety in defensive sectors last week.

Read more »

A smiling woman at a hardware shop selects paint colours from a wall display.
Broker Notes

Wesfarmers shares: Buy, hold or sell?

A leading analyst delivers his verdict on Wesfarmers shares.

Read more »

An arrow crashes through the ground as a businessman watches on.
Share Fallers

After falling 43% in a week, are Cochlear shares now a buy?

Is this drop a warning sign?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, CSL, and DroneShield shares

Are these hugely popular shares in the buy zone or not? Let's find out.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Share Market News

How much do I need to invest in ASX shares to earn a $500 monthly passive income?

A $500 per month passive income is more achievable than you'd think.

Read more »